198 related articles for article (PubMed ID: 32566062)
1. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment.
Reis-Pina P; Acharya A; Barbosa A; Lawlor PG
Pain Res Manag; 2020; 2020():6190862. PubMed ID: 32566062
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
[TBL] [Abstract][Full Text] [Related]
4. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
[TBL] [Abstract][Full Text] [Related]
5. Cancer Pain With a Neuropathic Component: A Cross-sectional Study of Its Clinical Characteristics, Associated Psychological Distress, Treatments, and Predictors at Referral to a Cancer Pain Clinic.
Reis-Pina P; Acharya A; Lawlor PG
J Pain Symptom Manage; 2018 Feb; 55(2):297-306. PubMed ID: 28870800
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.
Mercadante S; Adile C; Masedu F; Valenti M; Aielli F
J Pain Symptom Manage; 2019 May; 57(5):966-970. PubMed ID: 30822530
[TBL] [Abstract][Full Text] [Related]
7. Interference with daily functioning by breakthrough pain in patients with cancer.
Kang JH; Koh SJ; Oh SY; Kim RB; Shin SH; Lee YG; Kim BS; Ryoo HM; Yoon SY; Jang JS; Oh HS; Choi YJ; Lee MH; Lee KH
Support Care Cancer; 2020 Nov; 28(11):5177-5183. PubMed ID: 32056013
[TBL] [Abstract][Full Text] [Related]
8. From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations.
Løhre ET; Klepstad P; Bennett MI; Brunelli C; Caraceni A; Fainsinger RL; Knudsen AK; Mercadante S; Sjøgren P; Kaasa S;
J Pain Symptom Manage; 2016 Jun; 51(6):1013-9. PubMed ID: 26921493
[TBL] [Abstract][Full Text] [Related]
9. A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting.
Baek SK; Kim DY; Kang SY; Sym SJ; Kim YS; Lee JY
Cancer Res Treat; 2016 Apr; 48(2):768-74. PubMed ID: 26511815
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough cancer pain in 2020.
Løhre ET; Thronæs M; Klepstad P
Curr Opin Support Palliat Care; 2020 Jun; 14(2):94-99. PubMed ID: 32332210
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
Mercadante S; Masedu F; Valenti M; Aielli F
Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
[TBL] [Abstract][Full Text] [Related]
12. Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
Camps Herrero C; Reina Zoilo JJ; Monge Martín D; Caballero Martínez F; Guillem Porta V; Aranda Aguilar E; Carrato Mena A; Díaz-Rubio García E; García-Foncillas López J; Feijóo Saus M; López López R
Clin Transl Oncol; 2019 Mar; 21(3):380-390. PubMed ID: 30094793
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain.
Tagami K; Okizaki A; Miura T; Watanabe YS; Matsumoto Y; Morita T; Fujimori M; Kinoshita H
J Palliat Med; 2018 Nov; 21(11):1636-1640. PubMed ID: 29975582
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Treatment of Breakthrought Pain (BTcP) in Palliative Care.
Husic S; Imamovic S; Matic S; Sukalo A
Med Arch; 2017 Aug; 71(4):246-250. PubMed ID: 28974843
[TBL] [Abstract][Full Text] [Related]
15. [Fentanyl buccal tablets in the treatment of breakthrough cancer pain. German cohort of a pan-European multicentre study].
Lux EA; Schwittay A; Kleeberg UR; Papke J
MMW Fortschr Med; 2018 Jul; 160(Suppl 4):18-23. PubMed ID: 29974433
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature.
Deandrea S; Corli O; Consonni D; Villani W; Greco MT; Apolone G
J Pain Symptom Manage; 2014 Jan; 47(1):57-76. PubMed ID: 23796584
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
Masel EK; Landthaler R; Gneist M; Watzke HH
Support Care Cancer; 2018 Feb; 26(2):491-497. PubMed ID: 28849261
[TBL] [Abstract][Full Text] [Related]
20. Adequacy of cancer-related pain management and predictors of undertreatment at referral to a pain clinic.
Reis-Pina P; Lawlor PG; Barbosa A
J Pain Res; 2017; 10():2097-2107. PubMed ID: 28919809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
